HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by IFM Investors Pty Ltd

IFM Investors Pty Ltd lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,933 shares of the company’s stock after selling 183 shares during the quarter. IFM Investors Pty Ltd’s holdings in HCA Healthcare were worth $16,636,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in HCA. Fisher Asset Management LLC purchased a new position in HCA Healthcare in the fourth quarter worth approximately $223,000. Dynamic Advisor Solutions LLC boosted its holdings in shares of HCA Healthcare by 3.0% in the 1st quarter. Dynamic Advisor Solutions LLC now owns 5,405 shares of the company’s stock valued at $1,803,000 after buying an additional 156 shares in the last quarter. Kingswood Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the first quarter worth approximately $566,000. Sunbelt Securities Inc. grew its position in HCA Healthcare by 284.1% in the 1st quarter. Sunbelt Securities Inc. now owns 1,882 shares of the company’s stock valued at $628,000 after buying an additional 1,392 shares during the last quarter. Finally, GoalVest Advisory LLC lifted its holdings in HCA Healthcare by 83.7% in the first quarter. GoalVest Advisory LLC now owns 395 shares of the company’s stock valued at $132,000 after acquiring an additional 180 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HCA has been the subject of several research reports. Leerink Partners lifted their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Oppenheimer increased their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, Truist Financial increased their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $367.15.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $6.24 on Thursday, reaching $403.79. 1,130,800 shares of the company’s stock were exchanged, compared to its average volume of 1,137,155. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market capitalization of $105.76 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.44 and a beta of 1.67. The company has a fifty day moving average of $394.72 and a 200-day moving average of $352.30. HCA Healthcare, Inc. has a twelve month low of $220.55 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the business earned $4.29 earnings per share. The company’s revenue was up 10.3% on a year-over-year basis. On average, research analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,345 shares of company stock valued at $5,747,945 in the last 90 days. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.